Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinoma
Cell Reports · 2023
DOI: 10.1016/j.celrep.2023.113307 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Yuewei Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery & Cancer, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Antineoplastic Agents, Ovarian Neoplasms. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Imperial College London, China Scholarship Council, Cancer Research UK.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery & Cancer, Imperial College London, London, UK.
- Department of Surgery & Cancer, Imperial College London, London, UK; Ovarian Cancer Action Research Centre, Department of Surgery & Cancer, Imperial College London, London, UK.
- Department of Surgery & Cancer, Imperial College London, London, UK; Ovarian Cancer Action Research Centre, Department of Surgery & Cancer, Imperial College London, London, UK. Electronic address: h.keun@imperial.ac.uk.
- Department of Surgery & Cancer, Imperial College London, London, UK; Ovarian Cancer Action Research Centre, Department of Surgery & Cancer, Imperial College London, London, UK. Electronic address: a.nijhuis@imperial.ac.…
Förderung
- Imperial College London
- China Scholarship Council
- Cancer Research UK
- NIHR Imperial Biomedical Research Centre
- Ovarian Cancer Action
Zitieren
APA
Xu, Y., Spear, S., Ma, Y., Lorentzen, M. P., Gruet, M., McKinney, F., Xu, Y., Wickremesinghe, C., Shepherd, M. R., McNeish, I., Keun, H. C., & Nijhuis, A. (2023). Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinoma. Cell Reports. https://doi.org/10.1016/j.celrep.2023.113307
Vancouver
Xu Y, Spear S, Ma Y, Lorentzen MP, Gruet M, McKinney F, et al. Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinoma. Cell Reports. 2023. doi:10.1016/j.celrep.2023.113307
BibTeX
@article{Xu2023,
author = {Xu, Yuewei and Spear, Sarah and Ma, Yurui and Lorentzen, Marc P and Gruet, Michael and McKinney, Flora and Xu, Yitao and Wickremesinghe, Chiharu and Shepherd, Madelen R and McNeish, Iain and Keun, Hector C and Nijhuis, Anke},
title = {Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinoma},
journal = {Cell Reports},
year = {2023},
doi = {10.1016/j.celrep.2023.113307}
}
EUVIMED